BHCM
MDT icon

Brevan Howard Capital Management’s Medtronic MDT Stock Holding History

Brevan Howard Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Buy
+2,485
New +$238K ﹤0.01% 1854
2024
Q4 		– Sell
-102,791
Closed -$9.25M – 1281
2024
Q3 		$9.25M Buy
+102,791
New +$8.65M 0.06% 73
2024
Q1 		– Sell
-13,522
Closed -$1.11M – 1214
2023
Q4 		$1.11M Buy
+13,522
New +$1.03M 0.01% 209

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brevan Howard Capital Management's MDT Position: Q1 2026 in Review

Brevan Howard Capital Management opened a new position in Medtronic (MDT) in Q1 2026: 2,485 shares worth $215K. The stake represents ﹤0.01% of the portfolio and ranks #1854 among its holdings. This is a return to the name: Brevan Howard Capital Management previously reported a position in MDT as recently as Q3 2024.

Brevan Howard Capital Management first reported a position in MDT in Q4 2023 and has held it in 3 quarters since. The position peaked at $9.25M in Q3 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Brevan Howard Capital Management held 2,485 shares of Medtronic worth $215K as of Q1 2026.
  • Medtronic was a new Brevan Howard Capital Management position in Q1 2026.
  • Medtronic made up ﹤0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #1854 holding.
  • Brevan Howard Capital Management first reported a position in Medtronic in Q4 2023 and has held it in 3 quarters since.
  • Brevan Howard Capital Management's Medtronic position peaked at $9.25M in Q3 2024.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.